相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cost-Effectiveness Analysis of Antiviral Therapies for Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients in China
Chi Zhang et al.
CLINICAL DRUG INVESTIGATION (2015)
Cost-effectiveness of sorafenib as a first-line treatment for advanced hepatocellular carcinoma
Pengfei Zhang et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib
Li Xu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib
Yu Yang et al.
LIVER INTERNATIONAL (2015)
Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma
Shoji Kubo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Hepatitis B viral load affects prognosis of hepatocellular carcinoma
Su Jong Yu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma
Calogero Camma et al.
HEPATOLOGY (2013)
Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction
Elisabeth R. Garwood et al.
LIVER TRANSPLANTATION (2013)
High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: A prospective cohort study
T. Yang et al.
EJSO (2012)
Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma
Liping Chen et al.
EUROPEAN JOURNAL OF CANCER (2012)
Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy
Cheng-Yuan Peng et al.
JOURNAL OF HEPATOLOGY (2012)
Prognostic indicators of survival in patients with compensated and decompensated cirrhosis
Alexander Zipprich et al.
LIVER INTERNATIONAL (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Liver cancer epidemic in China: Past, present and future
Jian Guo Chen et al.
SEMINARS IN CANCER BIOLOGY (2011)
Cost-Effectiveness of Nucleoside Analog Therapy for Hepatitis B in China: A Markov Analysis
Bin Wu et al.
VALUE IN HEALTH (2010)
Nucleotide Analogs for Patients with HBV-Related Hepatocellular Carcinoma Increase the Survival Rate through Improved Liver Function
Masahiko Koda et al.
INTERNAL MEDICINE (2009)
Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B
Maria Buti et al.
JOURNAL OF HEPATOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Economic evaluation of sunitinib malate in second-line treatment of metastatic renal cell carcinoma in Finland
Timo Purmonen et al.
CLINICAL THERAPEUTICS (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cost of cancer care: Issues and implications
Neal J. Meropol et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
Joseph F. Perz et al.
JOURNAL OF HEPATOLOGY (2006)
Management of patients with hepatitis B virus-induced cirrhosis
SK Fung et al.
JOURNAL OF HEPATOLOGY (2005)
Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China
L Ming et al.
HEPATOLOGY (2002)
分享论文
